← Leaderboards
Kun-Eek Kil
University Of Missouri-Columbia
$427,915
Attributed
$427,915
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $233.4K · FY2024–25$250K$187.5K$125K$62.5K$0
'24
'25
Funding mix
By agency
NIH$427,915 · 1
By mechanism
R21$427,915 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Adrenergic Agonists”
- Georgette Suidan · Cerevel Therapeutics, Llc$2,700,000
- Ina Nemet · Cleveland Clinic Lerner Com-Cwru$2,221,265
- Lee Schmidt · Uswm, Llc$1,458,371
- Veronica Lynch Massey · Uswm, Llc$1,458,371
- Maria Marianovich · Albert Einstein College Of Medicine$1,363,044
- Grace Kim Muller · Loyola University Chicago$1,207,364
Research focus
Adrenergic AgonistsAdrenergic Alpha-AntagonistsAdrenergic Beta-AntagonistsAdrenergic ReceptorAffectAffinityAging PopulationAlzheimer&AposAntagonistAnxiety DisordersAreaArrhythmiaAutoradiographyAutoreceptorsBehaviorBindingBiologicalBiological MonitoringBlood PressureBrainBrain DiseasesBrain RegionCarbonAdrenergic Agents
Grant awards (2)
Development of 1,4-Benzodioxane Derivatives as F-18 PET Radiotracers for Alpha-2C Adrenergic Receptors and Their Preclinical Evaluations$194,513
R21 · FY2025 · AG · contact PI
Development of 1,4-Benzodioxane Derivatives as F-18 PET Radiotracers for Alpha-2C Adrenergic Receptors and Their Preclinical Evaluations$233,402
R21 · FY2024 · AG · contact PI